Literature DB >> 22016835

Expanding roles of ZEB factors in tumorigenesis and tumor progression.

Ester Sánchez-Tilló, Laura Siles, Oriol de Barrios, Miriam Cuatrecasas, Eva C Vaquero, Antoni Castells, Antonio Postigo.   

Abstract

The ZEB family of transcription factors regulates key factors during embryonic development and cell differentiation but their role in cancer biology has only more recently begun to be recognized. Early evidence showed that ZEB proteins induce an epithelial-to-mesenchymal transition linking their expression with increased aggressiveness and metastasis in mice models and a wide range of primary human carcinomas. Reports over the last few years have found that ZEB proteins also play critical roles in the maintenance of cancer cell stemness, control of replicative senescence, tumor angiogenesis, overcoming of oncogenic addiction and resistance to chemotherapy. These expanding roles in tumorigenesis and tumor progression set ZEB proteins as potential diagnostic, prognostic and therapeutic targets.

Entities:  

Keywords:  Cancer; E-cadherin; EMT; ZEB1; ZEB2; cancer stem cells; chemotherapy resistance; transcription; tumor invasiveness

Year:  2011        PMID: 22016835      PMCID: PMC3196287     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  132 in total

1.  Coordinated histone modifications mediated by a CtBP co-repressor complex.

Authors:  Yujiang Shi; Jun-ichi Sawada; Guangchao Sui; El Bachir Affar; Johnathan R Whetstine; Fei Lan; Hidesato Ogawa; Margaret Po-Shan Luke; Yoshihiro Nakatani; Yang Shi
Journal:  Nature       Date:  2003-04-17       Impact factor: 49.962

2.  zag-1, a Zn-finger homeodomain transcription factor controlling neuronal differentiation and axon outgrowth in C. elegans.

Authors:  Irene Wacker; Valentin Schwarz; Edward M Hedgecock; Harald Hutter
Journal:  Development       Date:  2003-08       Impact factor: 6.868

3.  CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain.

Authors:  Jae-Hwan Kim; Eun-Jung Cho; Seong-Tae Kim; Hong-Duk Youn
Journal:  Nat Struct Mol Biol       Date:  2005-04-17       Impact factor: 15.369

4.  p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells.

Authors:  Andreia V Pinho; Ilse Rooman; Francisco X Real
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

Review 5.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

6.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

Review 7.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

8.  The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation.

Authors:  R Sekido; K Murai; J Funahashi; Y Kamachi; A Fujisawa-Sehara; Y Nabeshima; H Kondoh
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

9.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.

Authors:  Andreas Eger; Kirsten Aigner; Stefan Sonderegger; Brigitta Dampier; Susanne Oehler; Martin Schreiber; Geert Berx; Amparo Cano; Hartmut Beug; Roland Foisner
Journal:  Oncogene       Date:  2005-03-31       Impact factor: 9.867

10.  The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Authors:  K Aigner; B Dampier; L Descovich; M Mikula; A Sultan; M Schreiber; W Mikulits; T Brabletz; D Strand; P Obrist; W Sommergruber; N Schweifer; A Wernitznig; H Beug; R Foisner; A Eger
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more
  73 in total

1.  Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.

Authors:  Basavaraj Vastrad; Chanabasayya Vastrad; Ashok Godavarthi; Raghu Chandrashekar
Journal:  Med Oncol       Date:  2017-09-26       Impact factor: 3.064

2.  ZEB1 imposes a temporary stage-dependent inhibition of muscle gene expression and differentiation via CtBP-mediated transcriptional repression.

Authors:  Laura Siles; Ester Sánchez-Tilló; Jong-Won Lim; Douglas S Darling; Kristen L Kroll; Antonio Postigo
Journal:  Mol Cell Biol       Date:  2013-01-22       Impact factor: 4.272

3.  The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma.

Authors:  E Sánchez-Tilló; L Fanlo; L Siles; S Montes-Moreno; A Moros; G Chiva-Blanch; R Estruch; A Martinez; D Colomer; B Győrffy; G Roué; A Postigo
Journal:  Cell Death Differ       Date:  2013-09-06       Impact factor: 15.828

4.  Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.

Authors:  Dimiter B Avtanski; Arumugam Nagalingam; Michael Y Bonner; Jack L Arbiser; Neeraj K Saxena; Dipali Sharma
Journal:  Mol Oncol       Date:  2014-01-15       Impact factor: 6.603

5.  Downregulation of GRHL2 inhibits the proliferation of colorectal cancer cells by targeting ZEB1.

Authors:  Yingjun Quan; Runsen Jin; Ao Huang; Hongchao Zhao; Bo Feng; Lu Zang; Minhua Zheng
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

Review 6.  ZEB1: New advances in fibrosis and cancer.

Authors:  Lin Cheng; Ming-Yuan Zhou; Ying-Jian Gu; Lei Chen; Yun Wang
Journal:  Mol Cell Biochem       Date:  2021-01-08       Impact factor: 3.396

7.  Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression.

Authors:  Chu-An Wang; David Drasin; Catherine Pham; Paul Jedlicka; Vadym Zaberezhnyy; Michelle Guney; Howard Li; Raphael Nemenoff; James C Costello; Aik-Choon Tan; Heide L Ford
Journal:  Cancer Res       Date:  2014-10-27       Impact factor: 12.701

8.  ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.

Authors:  E Sánchez-Tilló; O de Barrios; E Valls; D S Darling; A Castells; A Postigo
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

9.  Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion.

Authors:  Pedro Rosmaninho; Susanne Mükusch; Valerio Piscopo; Vera Teixeira; Alexandre Asf Raposo; Rolf Warta; Romina Bennewitz; Yeman Tang; Christel Herold-Mende; Stefano Stifani; Stefan Momma; Diogo S Castro
Journal:  EMBO J       Date:  2018-06-14       Impact factor: 11.598

10.  GLS2 is protumorigenic in breast cancers.

Authors:  Marilia M Dias; Douglas Adamoski; Larissa M Dos Reis; Carolline F R Ascenção; Andre Luis Berteli Ambrosio; Sandra Martha Gomes Dias; Krishina R S de Oliveira; Ana Carolina Paschoalini Mafra; Alliny Cristiny da Silva Bastos; Melissa Quintero; Carolina de G Cassago; Igor M Ferreira; Carlos H V Fidelis; Silvana A Rocco; Marcio Chaim Bajgelman; Zachary Stine; Ioana Berindan-Neagoe; George A Calin
Journal:  Oncogene       Date:  2019-09-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.